Keyphrases
Tolerability
100%
Naproxen
100%
Rheumatoid Arthritis Treatment
100%
Nabumetone
100%
Rheumatoid Arthritis
57%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
57%
Diarrhea
42%
Gastrointestinal Side Effects
42%
Adverse Events
28%
High Incidence
28%
Randomized Double-blind
14%
Clinically Significant
14%
Adult Patients
14%
Group Studies
14%
Gastrointestinal Events
14%
Treatment Duration
14%
Therapeutic Response
14%
Treatment Phase
14%
2-phase
14%
Between-group
14%
Change from Baseline
14%
Washout Period
14%
Physician Global Assessment
14%
Global Assessment
14%
Lower Abdominal Pain
14%
Rheumatoid Arthritis Patients
14%
Swollen Joint
14%
Rheumatology
14%
Percentage Improvement
14%
Equipotent Doses
14%
Upper Abdominal Pain
14%
Gastrointestinal Safety
14%
Gastrointestinal
14%
Treatment-related Adverse Events
14%
Tender Joint
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tolerability
100%
Rheumatoid Arthritis
100%
Naproxen
100%
Nabumetone
100%
Inflammatory Arthritis
100%
Adverse Event
85%
Non-Steroidal Anti-Inflammatory Drug
57%
Diarrhea
42%
Physical Disease by Body Function
28%
Upper Abdominal Pain
14%
Lower Abdominal Pain
14%